Patients ask AI about their diagnosis before they ask their doctor.
Side effects, drug comparisons, coverage, alternatives. AI answers, names brands, and steers conversations with prescribers. Aethon makes sure your therapy is in those conversations.
The conversations driving demand in Pharmaceuticals.
Every sub-vertical has a handful of triggers that move AI from context to recommendation. Here’s the Pharmaceuticals starter set, tuned to your specific business in onboarding.
“I just got diagnosed with rheumatoid arthritis. What are the leading medications and how do they compare?”
- Drug class explainers
- Mechanism of action
- Side-effect profiles
- Patient stories
“I've been on this medication for three weeks and I'm getting headaches. Is that normal?”
- Side-effect prevalence
- Severity guidance
- When to call the doctor
- Switching options
“My insurance denied coverage for the new biologic. What are my options?”
- Patient assistance programs
- Copay cards
- Appeals guidance
- Biosimilar alternatives
“I want to ask my doctor about Wegovy. What questions should I bring?”
- Eligibility self-check
- Conversation guides
- Step-therapy explainers
- Real-world outcomes
Where Pharmaceuticals recommendations are formed.
These are the publications, communities, and platforms that disproportionately shape how AI names brands in your sub-vertical. The action queue is built to land you here.
Concrete deliverables for Pharmaceuticals teams.
Onboarding is fast because the work is concrete. Here’s what lands in your workspace in the first 30 days.
Therapy moment library
Diagnosis, side-effect, switching, access, and adherence moment patterns mapped to your therapeutic area and indications.
Live AI share-of-recommendation
Track your brand against named competitor therapies across ChatGPT, Claude, Gemini, and Perplexity. Indication-level and prescriber-segment splits.
Source-authority gap report
Where AI cites therapy comparisons in your category, and which patient communities, journals, and aggregators to land in first.
Compliant content action queue
Med-legal-reviewed patient explainers, prescriber-prep guides, and access-program education sized to your indication.
Pharmaceuticals questions, answered
Is this compliant with FDA promotional rules?
Aethon helps you understand and influence the unbranded conversation AI is already having. Branded content runs through your med-legal review the same way it always has. We do not bypass regulation.
Does AI actually recommend specific drugs?
In comparison and triage contexts, yes. AI weights mechanism-of-action explainers, outcomes data, and patient-community sentiment when comparing therapies in a class.
What about adverse-event reporting?
Aethon monitors AI's behavior in aggregate. If your team needs to flag adverse-event signals in monitored content, that integrates with your existing pharmacovigilance workflow.
Can we segment by therapeutic area?
Yes. Enterprise plans support multiple indication libraries, each with its own moment set, competitor list, and source-authority map.
How does this work for prescriber audiences?
We monitor HCP-prep prompts (the questions clinicians type into AI before patient visits) as a separate persona. The recommendation patterns diverge meaningfully from patient prompts.
Do you work with biosimilars and generics?
Yes. Biosimilar education is one of the highest-leverage moment categories because AI is actively shaping early prescriber and patient choice.
More across this industry.
Other specialties and deep-dives in this category.
See where your brand stands in Pharmaceuticals AI conversations.
Drop your domain. We’ll run your brand against the Pharmaceuticals moment library, show you where AI is naming you, where competitors are landing instead, and the three highest-leverage actions to fix it.